DocGo ROE 2021-2024 | DCGO
Current and historical return on equity (ROE) values for DocGo (DCGO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| DocGo ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-06-30 | $0.03B | $0.32B | 10.08% |
| 2024-03-31 | $0.02B | $0.32B | 7.36% |
| 2023-12-31 | $0.01B | $0.31B | 2.75% |
| 2023-09-30 | $0.01B | $0.29B | 2.81% |
| 2023-06-30 | $0.01B | $0.28B | 2.15% |
| 2023-03-31 | $0.02B | $0.28B | 7.72% |
| 2022-12-31 | $0.04B | $0.28B | 13.41% |
| 2022-09-30 | $0.05B | $0.27B | 20.56% |
| 2022-06-30 | $0.05B | $0.25B | 29.38% |
| 2022-03-31 | $0.04B | $0.24B | 32.24% |
| 2021-12-31 | $0.02B | $0.23B | 42.86% |
| 2021-06-30 | $-0.00B | $0.01B | -160.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.349B | $0.624B |
| DocGo Inc. is a provider of last-mile telehealth and integrated medical mobility services. DocGo Inc., formerly known as Motion Acquisition Corp., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $97.370B | 12.08 |
| Cencora (COR) | United States | $46.142B | 17.63 |
| ICON (ICLR) | Ireland | $23.387B | 21.01 |
| DiDi Global (DIDIY) | China | $22.455B | 0.00 |
| Avantor (AVTR) | United States | $16.248B | 24.64 |
| Natera (NTRA) | United States | $14.836B | 0.00 |
| Revvity (RVTY) | United States | $14.650B | 25.65 |
| Viatris (VTRS) | United States | $13.928B | 4.24 |
| BioMerieux (BMXMF) | France | $13.361B | 0.00 |
| CochLear (CHEOY) | Australia | $12.549B | 0.00 |
| Solventum (SOLV) | United States | $12.541B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.123B | 28.59 |
| Charles River Laboratories (CRL) | United States | $9.600B | 18.14 |
| Sonic Healthcare (SKHHY) | Australia | $8.566B | 0.00 |
| Doximity (DOCS) | United States | $7.827B | 49.60 |
| HealthEquity (HQY) | United States | $7.651B | 41.52 |
| Bausch + Lomb (BLCO) | Canada | $7.165B | 30.83 |
| PACS (PACS) | United States | $6.258B | 0.00 |
| Life Times (LTH) | United States | $5.174B | 43.25 |
| Organon (OGN) | United States | $4.467B | 4.54 |
| Sotera Health (SHC) | United States | $4.384B | 22.11 |
| Surgery Partners (SGRY) | United States | $4.016B | 44.49 |
| BrightSpring Health Services (BTSG) | United States | $2.762B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.761B | 0.00 |
| Concentras Parent (CON) | United States | $2.683B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.504B | 94.29 |
| Alignment Healthcare (ALHC) | United States | $2.058B | 0.00 |
| Premier (PINC) | United States | $2.005B | 9.01 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.922B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.557B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.543B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.507B | 7.57 |
| Progyny (PGNY) | United States | $1.456B | 25.60 |
| QDM (QDMI) | Hong Kong, SAR China | $1.370B | 35.88 |
| Establishment Labs Holdings (ESTA) | $1.262B | 0.00 | |
| CareDx (CDNA) | United States | $1.220B | 0.00 |
| Agilon Health (AGL) | United States | $1.160B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.108B | 12.06 |
| Embecta (EMBC) | United States | $0.818B | 5.45 |
| InnovAge Holding (INNV) | United States | $0.801B | 0.00 |
| SBC Medicals (SBC) | United States | $0.744B | 0.00 |
| Sharecare (SHCR) | United States | $0.532B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.468B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.436B | 0.00 |
| Enhabit (EHAB) | United States | $0.362B | 31.30 |
| Sera Prognostics (SERA) | United States | $0.236B | 0.00 |
| Biodesix (BDSX) | United States | $0.234B | 0.00 |
| Beauty Health (SKIN) | United States | $0.207B | 0.00 |
| ModivCare (MODV) | United States | $0.200B | 6.35 |
| Ascend Wellness Holdings (AAWH) | United States | $0.191B | 0.00 |
| LifeMD (LFMD) | United States | $0.190B | 0.00 |
| MultiPlan (MPLN) | United States | $0.178B | 0.00 |
| Nutex Health (NUTX) | United States | $0.126B | 0.00 |
| So-Young (SY) | China | $0.103B | 25.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.060B | 0.00 |
| OncoCyte (OCX) | United States | $0.052B | 0.00 |
| NeueHealth (NEUE) | United States | $0.046B | 1.83 |
| Co-Diagnostics (CODX) | United States | $0.041B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.035B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.033B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| Oncology Institute (TOI) | United States | $0.026B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.026B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.017B | 0.00 |
| XWELL (XWEL) | United States | $0.010B | 0.00 |
| KindlyMD (KDLY) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |